ARCHIVES

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

This article is from The Cancer Letter archive.

Vol. 36 No. 30 | August 6, 2010

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Seeks SBIR Applicants For Research On Detection Assays

July 3, 1998

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

Ohio State to study center expansion.

September 26, 2003

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991